⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
HRTX News
Heron Therapeutics, Inc.
Form 8-K
sec.gov
HRTX
Postoperative Pain Management Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight
globenewswire.com
VRTX
VTRS
HRTX
AXSM
Form 8-K
sec.gov
HRTX
Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026
globenewswire.com
HRTX
Form 8-K
sec.gov
HRTX
Form 8-K
sec.gov
HRTX
Form 8-K
sec.gov
HRTX
U.S. District Court Issues Decision Regarding CINVANTI® Patents
globenewswire.com
HRTX
Form 8-K
sec.gov
HRTX
Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance
globenewswire.com
HRTX